See more : Patrimoine et Commerce SA (PAT.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Pediatrix Medical Group, Inc. (MD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pediatrix Medical Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Bagfas Bandirma Gubre Fabrikalari A.S. (BAGFS.IS) Income Statement Analysis – Financial Results
- Glencore plc (GLEN.L) Income Statement Analysis – Financial Results
- SOC Telemed, Inc. (TLMD) Income Statement Analysis – Financial Results
- CS Disco, Inc. (LAW) Income Statement Analysis – Financial Results
- Spectra Systems Corporation (SCTQ) Income Statement Analysis – Financial Results
Pediatrix Medical Group, Inc. (MD)
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.99B | 1.97B | 1.91B | 1.73B | 3.51B | 3.65B | 3.46B | 3.18B | 2.78B | 2.44B | 2.15B | 1.82B | 1.59B | 1.40B | 1.29B | 1.07B | 917.64M | 818.55M | 693.70M | 619.63M | 551.20M | 465.48M | 354.60M | 243.08M | 227.00M | 185.40M | 128.90M | 80.80M | 43.90M | 32.80M |
| Cost of Revenue | 1.57B | 1.50B | 1.40B | 1.28B | 2.62B | 2.66B | 2.46B | 2.15B | 1.85B | 1.63B | 1.44B | 1.20B | 1.04B | 912.43M | 835.73M | 688.21M | 567.38M | 501.55M | 27.68M | 24.25M | 18.59M | 15.79M | 0.00 | 26.68M | 21.10M | 14.10M | 9.80M | 6.30M | 3.50M | 2.80M |
| Gross Profit | 421.57M | 467.03M | 513.24M | 449.32M | 892.00M | 989.51M | 1.00B | 1.03B | 928.01M | 806.52M | 710.31M | 613.88M | 551.04M | 489.13M | 452.54M | 380.07M | 350.26M | 317.00M | 666.02M | 595.38M | 532.61M | 449.69M | 354.60M | 216.40M | 205.90M | 171.30M | 119.10M | 74.50M | 40.40M | 30.00M |
| Gross Profit Ratio | 21.13% | 23.68% | 26.85% | 25.91% | 25.39% | 27.13% | 28.92% | 32.47% | 33.38% | 33.07% | 32.98% | 33.79% | 34.69% | 34.90% | 35.13% | 35.58% | 38.17% | 38.73% | 96.01% | 96.09% | 96.63% | 96.61% | 100.00% | 89.03% | 90.70% | 92.39% | 92.40% | 92.20% | 92.03% | 91.46% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 227.54M | 231.40M | 263.36M | 248.95M | 404.64M | 432.38M | 417.11M | 372.57M | 305.92M | 247.53M | 218.21M | 193.54M | 170.36M | 154.27M | 124.97M | 124.97M | 119.77M | 109.06M | 115.30M | 79.45M | 76.54M | 0.00 | 274.72M | 177.72M | 148.90M | 113.70M | 81.50M | 52.70M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.20M | 0.00 | 0.00 | 0.00 | 393.14M | 350.35M | 310.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 227.54M | 231.40M | 263.36M | 248.95M | 404.64M | 432.38M | 417.11M | 372.57M | 305.92M | 247.53M | 218.21M | 193.54M | 170.36M | 154.27M | 147.16M | 124.97M | 119.77M | 109.06M | 508.44M | 429.80M | 387.32M | 331.48M | 274.72M | 177.72M | 148.90M | 113.70M | 81.50M | 52.70M | 29.50M | 20.70M |
| Other Expenses | 186.70M | 35.64M | 32.15M | 28.44M | 78.86M | 111.28M | 102.88M | 89.26M | 64.23M | 45.99M | 39.97M | 30.82M | 25.29M | 21.95M | 16.45M | 13.07M | 9.59M | 9.47M | 9.92M | 9.35M | 8.41M | 6.14M | 21.44M | 13.81M | 12.10M | 8.70M | 4.50M | 1.80M | 400.00K | 200.00K |
| Operating Expenses | 414.24M | 267.03M | 295.50M | 277.39M | 483.50M | 543.66M | 519.98M | 461.84M | 370.14M | 293.52M | 258.18M | 224.36M | 215.65M | 176.22M | 163.61M | 826.25M | 129.36M | 118.53M | 518.36M | 439.15M | 395.72M | 337.62M | 296.16M | 191.53M | 161.00M | 122.40M | 86.00M | 54.50M | 29.90M | 20.90M |
| Cost & Expenses | 1.99B | 1.77B | 1.69B | 1.56B | 3.11B | 3.20B | 2.98B | 2.61B | 2.22B | 1.93B | 1.70B | 1.43B | 1.25B | 1.09B | 999.34M | 826.25M | 696.74M | 620.08M | 546.03M | 463.41M | 414.31M | 353.41M | 296.16M | 218.20M | 182.10M | 136.50M | 95.80M | 60.80M | 33.40M | 23.70M |
| Interest Income | 0.00 | 3.67M | 13.65M | 17.91M | 3.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 42.08M | 39.70M | 68.72M | 110.48M | 119.38M | 88.77M | 74.56M | 63.09M | 23.11M | 8.89M | 5.42M | 3.25M | 3.64M | 3.19M | 2.91M | 3.59M | 749.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 36.17M | 35.64M | 32.15M | 28.44M | 25.93M | 83.83M | 102.88M | 89.26M | 64.23M | 45.99M | 39.97M | 30.82M | 25.29M | 21.95M | 16.45M | 13.07M | 10.56M | 9.47M | 9.92M | 9.35M | 8.41M | 6.14M | 21.44M | 13.81M | 12.10M | 8.70M | 4.50M | 1.80M | 400.00K | 200.00K |
| EBITDA | 29.89M | 235.64M | 249.89M | 200.37M | 258.58M | 527.69M | 587.86M | 660.95M | 622.10M | 558.99M | 492.10M | 422.23M | 382.18M | 336.30M | 307.06M | 258.22M | 224.61M | 204.11M | 156.40M | 164.68M | 145.29M | 118.21M | 79.88M | 38.68M | 57.00M | 57.60M | 37.60M | 21.80M | 10.90M | 9.30M |
| EBITDA Ratio | 1.50% | 12.04% | 13.17% | 11.65% | 14.09% | 15.46% | 16.88% | 20.86% | 22.49% | 22.99% | 22.85% | 23.14% | 23.97% | 23.89% | 23.70% | 23.88% | 24.48% | 24.94% | 22.55% | 26.58% | 26.27% | 25.22% | 22.53% | 15.77% | 24.98% | 30.74% | 27.54% | 24.50% | 23.01% | 27.74% |
| Operating Income | 7.32M | 172.69M | 202.92M | 173.52M | 416.27M | 445.85M | 480.08M | 571.69M | 557.87M | 513.00M | 452.13M | 389.52M | 355.39M | 312.91M | 288.93M | 242.03M | 220.90M | 198.47M | 147.67M | 156.22M | 136.89M | 112.08M | 58.44M | 24.87M | 44.90M | 48.90M | 33.10M | 20.00M | 10.50M | 9.10M |
| Operating Income Ratio | 0.37% | 8.76% | 10.62% | 10.01% | 11.85% | 12.22% | 13.88% | 17.96% | 20.07% | 21.03% | 20.99% | 21.44% | 22.38% | 22.33% | 22.43% | 22.66% | 24.07% | 24.25% | 21.29% | 25.21% | 24.83% | 24.08% | 16.48% | 10.23% | 19.78% | 26.38% | 25.68% | 24.75% | 23.92% | 27.74% |
| Total Other Income/Expenses | -55.68M | -91.32M | -67.69M | -90.98M | -112.97M | 120.45M | -69.65M | -57.89M | -18.14M | -4.38M | -3.72M | -1.35M | -2.14M | -1.76M | -1.23M | -611.00K | 6.11M | 2.80M | 3.70M | -402.00K | -890.00K | -338.00K | -2.23M | -3.41M | -2.30M | -400.00K | 1.70M | 2.00M | 700.00K | 0.00 |
| Income Before Tax | -48.36M | 81.37M | 135.23M | 7.15M | -1.24B | 368.84M | 410.42M | 513.80M | 539.73M | 508.62M | 448.41M | 388.17M | 353.25M | 311.15M | 287.70M | 241.42M | 227.01M | 201.28M | 146.58M | 155.82M | 136.00M | 111.74M | 56.21M | 21.46M | 42.60M | 48.50M | 34.80M | 22.00M | 11.20M | 9.10M |
| Income Before Tax Ratio | -2.42% | 4.13% | 7.08% | 0.41% | -35.35% | 10.11% | 11.87% | 16.14% | 19.41% | 20.85% | 20.82% | 21.37% | 22.24% | 22.20% | 22.33% | 22.60% | 24.74% | 24.59% | 21.13% | 25.15% | 24.67% | 24.00% | 15.85% | 8.83% | 18.77% | 26.16% | 27.00% | 27.23% | 25.51% | 27.74% |
| Income Tax Expense | 12.05M | 18.81M | 27.24M | 16.73M | -91.89M | 100.21M | 90.05M | 189.20M | 204.04M | 191.41M | 167.90M | 147.26M | 135.25M | 108.46M | 111.90M | 94.74M | 86.99M | 76.81M | 57.54M | 57.54M | 51.67M | 42.96M | 25.78M | 10.47M | 17.60M | 19.40M | 13.90M | 8.90M | 4.50M | 3.70M |
| Net Income | -60.41M | 66.34M | 130.96M | -9.58M | -1.15B | 268.63M | 320.37M | 324.91M | 336.32M | 317.28M | 280.52M | 240.91M | 218.00M | 202.69M | 175.80M | 169.20M | 142.72M | 124.47M | 89.04M | 98.28M | 84.33M | 68.78M | 30.43M | 10.99M | 25.00M | 29.10M | 20.90M | 13.10M | 6.70M | 5.40M |
| Net Income Ratio | -3.03% | 3.36% | 6.85% | -0.55% | -32.73% | 7.37% | 9.26% | 10.21% | 12.10% | 13.01% | 13.02% | 13.26% | 13.73% | 14.46% | 13.65% | 15.84% | 15.55% | 15.21% | 12.84% | 15.86% | 15.30% | 14.78% | 8.58% | 4.52% | 11.01% | 15.70% | 16.21% | 16.21% | 15.26% | 16.46% |
| EPS | -0.72 | 0.79 | 1.54 | -0.11 | -13.77 | 2.95 | 3.42 | 3.47 | 3.59 | 3.30 | 2.77 | 2.41 | 2.23 | 2.17 | 1.87 | 1.85 | 1.48 | 1.30 | 0.47 | 0.51 | 0.89 | 0.67 | 0.36 | 0.18 | 0.40 | 0.24 | 0.09 | 0.11 | 0.04 | 0.04 |
| EPS Diluted | -0.73 | 0.79 | 1.53 | -0.11 | -13.77 | 2.93 | 3.42 | 3.47 | 3.58 | 3.18 | 2.77 | 2.41 | 2.23 | 2.13 | 1.87 | 1.80 | 1.43 | 1.26 | 0.46 | 0.48 | 0.86 | 0.65 | 0.34 | 0.17 | 0.40 | 0.23 | 0.08 | 0.11 | 0.04 | 0.03 |
| Weighted Avg Shares Out | 84.02M | 83.47M | 84.83M | 83.40M | 83.50M | 91.10M | 92.43M | 92.42M | 93.74M | 96.03M | 100.91M | 99.55M | 97.87M | 93.26M | 90.92M | 92.83M | 96.92M | 95.85M | 185.94M | 190.65M | 94.97M | 102.49M | 84.64M | 63.04M | 62.05M | 60.99M | 121.13M | 116.28M | 52.20M | 52.04M |
| Weighted Avg Shares Out (Dil) | 82.20M | 84.12M | 85.83M | 83.40M | 83.50M | 91.61M | 93.72M | 93.72M | 93.96M | 99.89M | 101.21M | 100.04M | 97.87M | 95.14M | 92.94M | 94.32M | 99.81M | 98.77M | 192.16M | 198.94M | 98.31M | 106.52M | 89.91M | 64.21M | 63.44M | 63.95M | 121.13M | 116.44M | 52.20M | 52.04M |
Pediatrix (MD) Q2 Earnings Meet Estimates, Revenues Up Y/Y
Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates
Pediatrix Medical Group Reports Second Quarter Results
MD vs. PGNY: Which Stock Is the Better Value Option?
Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023
Why Is Pediatrix Medical Group (MD) Down 4.9% Since Last Earnings Report?
cultivate(MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA
Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat
Pediatrix Board Appoints Sylvia Young as Independent Director
Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference
Source: https://incomestatements.info
Category: Stock Reports